CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas

被引：4

作者：

不详

机构：

[1] Institut National de la Santé et de la Recherche Médicale (INSERM) U1160, Institut de Recherche Saint-Louis, Paris

[2] Université Paris Cité, Institut de Recherche Saint-Louis, Paris

[3] Pathology Department, Saint-Louis Hospital, Assistance Publique–Hôpitaux de Paris, Paris

[4] Institut National de la Santé et de la Recherche Médicale (INSERM) U976 HIPI, Institut de Recherche Saint-Louis, Paris

[5] Department of Dermatology, Charité Hospital, Berlin

[6] Department of Dermatology, Saint-Louis Hospital, Assistance Publique–Hôpitaux de Paris, Paris

[7] Pharmacy, Saint-Louis Hospital, Assistance Publique–Hôpitaux de Paris, Paris

[8] Department of Hematology, Centre Hospitalier Universitaire (CHU) Clermont-Ferrand, Clermont-Ferrand

[9] Department of Dermatology, Centre Hospitalier Universitaire (CHU) Clermont-Ferrand, Clermont-Ferrand

[10] Hematology Laboratory, Centre Hospitalier Universitaire (CHU) Clermont-Ferrand, Clermont-Ferrand

[11] Hematology Laboratory, Saint-Louis Hospital, Assistance Publique–Hôpitaux de Paris, Paris

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 07期

关键词：

D O I：

10.1016/j.jid.2023.01.009

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：1329 / +

页数：6

共 12 条

[1] CD38 LIGATION INDUCES DISCRETE CYTOKINE MESSENGER-RNA EXPRESSION IN HUMAN CULTURED LYMPHOCYTES [J].

AUSIELLO, CM ;

URBANI, F ;

LASALA, A ;

FUNARO, A ;

MALAVASI, F .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (05) :1477-1480

[2] Lenalidomide enhances MOR202-dependent macrophage -mediated effector functions via the vitamin D pathway [J].

Busch, Leonhard ;

Mougiakakos, Dimitrios ;

Buettner-Herold, Maike ;

Mueller, Miriam J. ;

Volmer, Dietrich A. ;

Bach, Christian ;

Fabri, Mario ;

Bittenbring, Joerg T. ;

Neumann, Frank ;

Boxhammer, Rainer ;

Nolting, Jens ;

Bisht, Savita ;

Boettcher, Martin ;

Jitschin, Simon ;

Hoffmann, Markus H. ;

Balzer, Heidi ;

Beier, Fabian ;

Gezer, Deniz ;

Dudziak, Diana ;

Gelse, Kolja ;

Hennig, Friedrich F. ;

Pallasch, Christian P. ;

Spriewald, Bernd ;

Mackensen, Andreas ;

Bruns, Heiko .

LEUKEMIA, 2018, 32 (11) :2445-2458

[3] Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple Myeloma [J].

Feng, Xiaoyan ;

Zhang, Li ;

Acharya, Chirag ;

An, Gang ;

Wen, Kenneth ;

Qiu, Lugui ;

Munshi, Nikhil C. ;

Tai, Yu-Tzu ;

Anderson, Kenneth C. .

CLINICAL CANCER RESEARCH, 2017, 23 (15) :4290-4300

[4] Therapeutic Potential and Role of CD38 in Cutaneous T-Cell Lymphoma Pathogenesis [J].

Isabelle, Colleen ;

McConnell, Kathleen ;

Boles, Amy E. ;

Brammer, Jonathan E. ;

Berge, Robyn ;

Portocarrero, Carla ;

Chakravarti, Nitin ;

Porcu, Pierluigi ;

Nikbakht, Neda ;

Mishra, Anjali .

BLOOD, 2022, 140 :9216-9218

[5] Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sezary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project [J].

Kim, Youn H. ;

Tavallaee, Mahkam ;

Sundram, Uma ;

Salva, Katrin A. ;

Wood, Gary S. ;

Li, Shufeng ;

Rozati, Sima ;

Nagpal, Seema ;

Krathen, Michael ;

Reddy, Sunil ;

Hoppe, Richard T. ;

Nguyen-Lin, Annie ;

Weng, Wen-Kai ;

Armstrong, Randall ;

Pulitzer, Melissa ;

Advani, Ranjana H. ;

Horwitz, Steven M. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (32) :3750-+

[6] Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma [J].

Krejcik, Jakub ;

Casneuf, Tineke ;

Nijhof, Inger S. ;

Verbist, Bie ;

Bald, Jaime ;

Plesner, Torben ;

Syed, Khaja ;

Liu, Kevin ;

van de Donk, Niels W. C. J. ;

Weiss, Brendan M. ;

Ahmadi, Tahamtan ;

Lokhorst, Henk M. ;

Mutis, Tuna ;

Sasser, A. Kate .

BLOOD, 2016, 128 (03) :384-394

[7] Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma [J].

Lokhorst, H. M. ;

Plesner, T. ;

Laubach, J. P. ;

Nahi, H. ;

Gimsing, P. ;

Hansson, M. ;

Minnema, M. C. ;

Lassen, U. ;

Krejcik, J. ;

Palumbo, A. ;

van de Donk, N. W. C. J. ;

Ahmadi, T. ;

Khan, I. ;

Uhlar, C. M. ;

Wang, J. ;

Sasser, A. K. ;

Losic, N. ;

Lisby, S. ;

Basse, L. ;

Brun, N. ;

Richardson, P. G. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (13) :1207-1219

[8] A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma [J].

Martin, Thomas ;

Baz, Rachid ;

Benson, Don M. ;

Lendvai, Nikoletta ;

Wolf, Jeffrey ;

Munster, Pamela ;

Lesokhin, Alexander M. ;

Wack, Claudine ;

Charpentier, Eric ;

Campana, Frank ;

Vij, Ravi .

BLOOD, 2017, 129 (25) :3294-3303

[9] Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC [J].

Olsen, Elise A. ;

Whittaker, Sean ;

Willemze, Rein ;

Pinter-Brown, Lauren ;

Foss, Francine ;

Geskin, Larisa ;

Schwartz, Lawrence ;

Horwitz, Steven ;

Guitart, Joan ;

Zic, John ;

Kim, Youn H. ;

Wood, Gary S. ;

Duvic, Madeleine ;

Ai, Wei ;

Girardi, Michael ;

Gru, Alejandro ;

Guenova, Emmanuella ;

Hodak, Emmilia ;

Hoppe, Richard ;

Kempf, Werner ;

Kim, Ellen ;

Lechowicz, Mary Jo ;

Ortiz-Romero, Pablo ;

Papadavid, Evangelia ;

Quaglino, Pietro ;

Pittelkow, Mark ;

Prince, H. Miles ;

Sanches, Jose Antonio ;

Sugaya, Makoto ;

Vermeer, Maarten ;

Zain, Jasmine ;

Knobler, Robert ;

Stadler, Rudolf ;

Bagot, Martine ;

Scarisbrick, Julia .

BLOOD, 2022, 140 (05) :419-437

[10] CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study [J].

Quaglino, Pietro ;

Novelli, Mauro ;

Fava, Paolo ;

Ortolan, Erika ;

Astrua, Chiara ;

Tonella, Luca ;

Tomasini, Carlo Francesco ;

Senetta, Rebecca ;

Ribero, Simone ;

Ponti, Renata ;

Fierro, Maria Teresa ;

Funaro, Ada .

DISEASE MARKERS, 2022, 2022

← 1 2 →